Clinicians’ adherence to international guidelines in the clinical care of adults with inflammatory bowel disease

References

• Kassam Z, Belga S, Roifman I, et al. Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis. 2014;20:2483–2492.
   PubMed Web of Science ®Google Scholar
• Standards for the Healthcare of People who have Inflammatory Bowel Disease (IBD). 2013Update. The IBD Standards Group. Published by Oyster Healthcare Communications Ltd. [cited 2017 Jan 16] Available from: https://www.crohnsandcolitis.org.uk/improving-care-services/health-services/ibd-standards
   Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 e42. quiz e30.
   PubMed Web of Science ®Google Scholar
• Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol. 2013;11:43–48.
   PubMed Web of Science ®Google Scholar
• American Gastroenterological Association. Adult inflammatory bowel disease physician performance measures set. [cited 2015 Jul 10]. Available from: http://www.gastro.org/practice/quality-initiatives/IBD_Measures.pdf
   Google Scholar
• Melmed GY, Siegel CA. Quality improvement in inflammatory bowel disease. Gastroenterol Hepatol. 2013;9:286–292.
   Google Scholar
• Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991–1030.
   PubMed Web of Science ®Google Scholar
• Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.
   PubMed Web of Science ®Google Scholar
• Tinsley A, Naymagon S, Trindade AJ, et al. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol. 2013;47:e1–e6.
   PubMed Web of Science ®Google Scholar
• Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn’s disease: what is the actual risk? Gut. 2011;60:1178–1181.
   PubMed Web of Science ®Google Scholar
• Hinojosa J, Gisbert JP, Gomollon F, et al. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on Crohn’s disease: a real-life survey in Spain. J Crohns Colitis. 2012;6:763–770.
   PubMed Web of Science ®Google Scholar
• Classifications. 2016. [Internet]; [cited 2016 May 3]. Available from: http://www.who.int/classifications/icd/en/.)
   Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Ellis J, Mulligan I, Rowe J, et al. Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet. 1995;346:407–410.
   PubMed Web of Science ®Google Scholar
• McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–2645.
   PubMed Web of Science ®Google Scholar
• Singleton JW, Hanauer SB, Gitnick GL, et al. Mesalamine capsules for the treatment of active Crohn’s disease: results of a 16-week trial. Pentasa Crohn’s Disease Study Group. Gastroenterology. 1993;104:1293–1301.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Jewell DP. Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn’s disease. Digestion. 1990;45:88–92.
   PubMed Web of Science ®Google Scholar
• Rasmussen SN, Lauritsen K, Tage-Jensen U, et al. 5-Aminosalicylic acid in the treatment of Crohn’s disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa. Scand J Gastroenterol. 1987;22:877–883.
   PubMed Web of Science ®Google Scholar
• Reddy SI, Friedman S, Telford JJ, et al. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol. 2005;100:1357–1361.
   PubMed Web of Science ®Google Scholar
• Paoluzi OA, Iacopini F, Pica R, et al. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study. Aliment Pharmacol Ther. 2005;21:1111–1119.
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment Pharmacol Ther. 2006;24 Suppl 3:37–40.
   PubMed Web of Science ®Google Scholar
• Song HK, Jung S-A, Cha JM, et al. Adherence to quality measures for inflammatory bowel disease in Korea: Questionnaire study based on American Gastroenterological Assocaition Adult Inflammatory Bowel Disease Physician Performance Measures Set. ECCO Abstract. 2014;568.
   Google Scholar
• Rana FA, Tate D, Shaikh MM, et al. Bone mineral density measurement using dual energy X-ray in inflammatory bowel disease patients – are we screening our patients for osteoporosis? ECCO Abstract. 2014;544.
   Google Scholar
• Targownik LE, Bernstein CN, Nugent Z, et al. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol. 2013;11:278–285.
   PubMed Web of Science ®Google Scholar
• Walsh AJ, Weltman M, Burger D, et al. Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2013;7:e449–e456.
   PubMedGoogle Scholar
• Nair S, Hobday D. Screening for opportunistic infection prior to initiating immunomodulator therapy in IBD patients – practice in the North East of England. ECCO Abstract. 2014;351.
   Google Scholar
• Long MD, Herfarth HH, Pipkin CA, et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268–274.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141:1621–1628 e1-5.
   PubMed Web of Science ®Google Scholar
• Ariyaratnam J, Subramanian V. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2014;109:163–169.
   PubMed Web of Science ®Google Scholar
• Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–1080.
   PubMed Web of Science ®Google Scholar
• National Cervical Screening Program. 2016; [cited 2016 Jun 8]. Available from: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/content/future-changes-cervical.
   Google Scholar
• Dezfoli S, Melmed GY. Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol. 2012;8:504–512.
   Google Scholar
• Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Aliment Pharmacol Ther. 2005;21:921–931.
   PubMed Web of Science ®Google Scholar
• Biedermann L, Fournier N, Misselwitz B, et al. High rates of smoking especially in female crohn's disease patients and low use of supportive measures to achieve smoking cessation–data from the swiss ibd cohort study. ECCOJC. 2015;9:819–829.
   Web of Science ®Google Scholar
• Saadoune N, Peyrin-Biroulet L, Baumann C, et al. Beliefs and behaviour about smoking among inflammatory bowel disease patients. Eur J Gastroenterol Hepatol. 2015;27:797–803.
   PubMed Web of Science ®Google Scholar
• Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103:1989–1997.
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481–1491.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Mikocka-Walus A. Psychological aspects of inflammatory bowel disease – a biopsychosocial approach. 2014; p. XVIII–XXXIV.
   Google Scholar
• Moser G, Genser D, Tribl B, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1995;90:1904.
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus A, Andrews JM, Rampton D, et al. How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. J Crohns Colitis. 2014;8:1668–1674.
   PubMed Web of Science ®Google Scholar
• Thomas LH, Cullum NA, McColl E, et al. Guidelines in professions allied to medicine. Cochrane Database System Rev. 1999(1).
   Google Scholar
• Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312:71–72.
   PubMed Web of Science ®Google Scholar
• van Achterberg T, Schoonhoven L, Grol R. Nursing implementation science: how evidence-based nursing requires evidence-based implementation. J Nurs Scholarsh. 2008;40:302–310.
   PubMed Web of Science ®Google Scholar
• Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362:1225–1230.
   PubMed Web of Science ®Google Scholar
• Wilson B, Lonnfors S, Hommes D, et al. A European Crohn’s and ulcerative colitis patient life IMPACT survey. Eighth Congress of the European Crohn’s and Colitis Organisation. 2012;Abstract P406.
   Google Scholar
• Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care. 2009;18:385–392.
   PubMed Web of Science ®Google Scholar
• Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol. 2009;23:613–617.
   PubMed Web of Science ®Google Scholar
• van Rijn AF, Fockens P, Siersema PD, et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn’s colitis patients in the Netherlands. WJG. 2009;15:226–230.
   PubMed Web of Science ®Google Scholar